Showing results (1-10 of 874) with videos related to
Sort By:
Pageof 88
Clinical and Experimental Rheumatology|July 1, 2017
Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™)Oliver Distler, Kevin K Brown, Jörg H W Distler, et al.Annals of the Rheumatic Diseases|August 8, 2020
Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trialJames R Seibold, Toby M Maher, Kristin B Highland, et al.Expert Review of Clinical Immunology|October 1, 2019
Current and future perspectives on management of systemic sclerosis-associated interstitial lung diseaseOliver Distler, Elizabeth R Volkmann, Anna Maria Hoffmann-Vold, et al.The New England Journal of Medicine|May 22, 2019
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung DiseaseOliver Distler, Kristin B Highland, Martina Gahlemann, et al.ERJ Open Research|March 1, 2021
Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic reviewAnna-Maria Hoffmann-Vold, Toby M Maher, Edward E Philpot, et al.Respiratory Research|July 25, 2020
The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating diseaseAnna-Maria Hoffmann-Vold, Yannick Allanore, Elisabeth Bendstrup, et al.Respiratory Research|July 5, 2022
Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjectsToby M Maher, Arnaud Bourdin, Elizabeth R Volkmann, et al.Expert Opinion on Medical Diagnostics|March 19, 2013
The diagnosis of idiopathic pulmonary fibrosis and its complicationsToby M MaherClinics in Chest Medicine|February 28, 2012
Idiopathic pulmonary fibrosis: pathobiology of novel approaches to treatmentToby M MaherImmunology and Allergy Clinics of North America|October 30, 2012
A clinical approach to diffuse parenchymal lung diseaseToby M MaherPageof 88